Clinical trial
Timing and Duration of Acute Hepatitis C Treatment
NCT00241618 · Ain Shams University, Other · Completed
Key facts
| NCT number | NCT00241618 |
|---|---|
| Title | Timing and Duration of Acute Hepatitis C Treatment |
| Official title | Phase IV Study of Treatment of Acute Hepatitis C With Pegylated Interferon |
| Lead sponsor | Ain Shams University, Other |
| Collaborators | University Hospital Freiburg Beth Israel Deaconess Medical Center Alexander von Humboldt Association Fulbright National Institute of Allergy and Infectious Diseases (NIAID) NIH Tempus AI Industry… |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Pegylated interferon alpha 2, Ribavirin |
| Enrollment | 180 |
| Start date | Jan 1, 2002 |
| Completion | Jan 1, 2006 |
| First posted | Oct 19, 2005 |
| Last update posted | Sep 11, 2006 |
| Countries | Egypt |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: